Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds
New research reveals how low blood sugar can damage the retina in diabetes, highlighting potential treatments targeting specific proteins to prevent vision loss.
ARVO 2025: Lens thickness as a significant biomarker for accommodation in presbyopia
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
US FDA gives Atia Vision go-ahead to begin clinical study of the OmniVu Lens System
The novel intraocular lens works to restore dynamic range of vision following cataract surgery.
Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in US
The OTC eye drops contain low-dose brimonidine tartrate 0.025%.
US FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
The drop has the potential to become the first-ever ocular surface indication for an IG.
Health care leader coalition launches Alliance for Healthcare from the Eye initiative
The cross sector initiative that intends to drive a shift from reactive to proactive health care by leveraging ocular data through the means of oculomics.
ARVO 2025: OCT-based marker for accommodative effort in presbyopes
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
VSP Vision selected as 2025 US Best Managed Company Gold Standard award winner
The award marks the company's fifth consecutive recognition from the program.
Intalight's DREAM OCT platform receives CE Mark
DREAM is an acronym for deep imaging depth, rapid sweeping speed, extensive scan range, accurate results, and multimodal imaging capabilities.
Significant association between COVID-19 and astigmatism in Hong Kong schoolchildren
AI systems demonstrate promising potential for DR screening, study finds
In total, 613,690 images used for screening were included in the study.
Takeaways from this week in optometry: May 12 - May 16
Catch up on the top stories in optometry during the week of May 12-May 16.
Nicox releases results from Whistler phase 3b trial in IOP-lowering eye drops
NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action (nitric oxide and prostaglandin analogue).
Evaluating the effects of perfluorohexyloctane on biometry: A Q&A with Kayla Karpuk, OD, from ARVO 2025
Can a drop of perfluorohexyloctane, known to persist in the tear film, influence the precision of keratometry and ultimately affect surgical planning?
Researchers find Alzheimer disease detection potential in blood-based, retinal biomarkers
The recent study details the diagnostic value of a multimodal model utilizing both types of biomarkers when compared to unimodal models.
AOA announces top 5 posters in the 2025 live education session lineup
Because this year’s session is joint between the AOA and WCO, the session will feature work from members across both groups.
Q&A with Karl Stonecipher, MD, on outcomes of LASIK using the Teneo platform to correct high myopia
Researchers develop AI system that clarifies images of RPE, making cells visible
The system was taught quality standards by being fed more than 1400 images from different parts of the retina taken by adaptive-optics ophthalmoscopy.
West Virginian legislators sign scope expansion bill into law
The bill, which passed on May 1, allows for West Virginian ODs to provide certain in-office procedures.
Bausch + Lomb launches Zenlens Chroma HOA scleral lens in US
Bausch + Lomb’s propriety Zenlens technology, which includes SmartCurve and Bi-Elevation, apply custom HOA correction to the lens to reduce visual disturbance, blurring, and distortion.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "West Virginian legislators and representatives from the West Virginia Association of Optometric Physicians in the West Virginia Senate Chambers. Image credit: American Optometric Association")
